These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9160765)

  • 61. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
    van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Natriuretic effect of nitrendipine is preceded by transient systemic and renal hemodynamic effects.
    Krekels MM; Gaillard CA; Viergever PP; Van Es PN; Lavrijssen AT; De Leeuw PW
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):33-8. PubMed ID: 9140675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
    Elung-Jensen T; Heisterberg J; Sonne J; Strandgaard S; Kamper AL
    Eur J Clin Pharmacol; 2005 Apr; 61(2):87-96. PubMed ID: 15761754
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
    Springate J; Van Liew J; Ganten D
    Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.
    Kwakernaak AJ; Roksnoer LC; Lambers Heerspink HJ; van den Berg-Garrelds I; Lochorn GA; van Embden Andres JH; Klijn MA; Kobori H; Danser AH; Laverman GD; Navis GJ
    PLoS One; 2017; 12(1):e0169258. PubMed ID: 28118402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L; Rutkowski P; Renke M; Rutkowski B
    Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients.
    McCarron DA; Weder AB; Egan BM; Krishna GG; Morris CD; Cohen M; Oparil S
    Am J Hypertens; 1997 Jan; 10(1):68-76. PubMed ID: 9008250
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sustained-release isradipine compared with spirapril in the treatment of elderly patients with isolated systolic hypertension.
    Tomlinson B; Woo J; Critchley JA; Or KK; Chan TY; Sanderson JE
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):35S-39S. PubMed ID: 7946177
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term effects of isradipine on blood pressure and renal function.
    Pedersen OL; Krusell LR; Sihm I; Jespersen LT; Thomsen K
    Am J Med; 1989 Apr; 86(4A):15-8. PubMed ID: 2523650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide.
    Sihm I; Thygesen K; Krusell LR; Lederballe O
    Blood Press; 2000; 9(6):346-54. PubMed ID: 11212064
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
    van Paassen P; de Zeeuw D; de Jong PE
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serial changes in blood pressure, renal function, endothelin and lipoprotein (a) during the first 9 days of cyclosporin therapy in males.
    Sturrock ND; Lang CC; MacFarlane LJ; Dockrell ME; Ryan M; Webb DJ; Struthers AD
    J Hypertens; 1995 Jun; 13(6):667-73. PubMed ID: 7594425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis.
    Toto RD; Mitchell HC; Lee HC; Milam C; Pettinger WA
    Ann Intern Med; 1991 Oct; 115(7):513-9. PubMed ID: 1883120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.